Adrienne Farid - 06 Mar 2024 Form 4 Insider Report for Century Therapeutics, Inc. (IPSC)

Role
Chief Operations Officer
Signature
/s/ Adrienne Farid
Issuer symbol
IPSC
Transactions as of
06 Mar 2024
Net transactions value
-$214,562
Form type
4
Filing time
08 Mar 2024, 18:29:55 UTC
Previous filing
21 Feb 2024
Next filing
11 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IPSC Common Stock Options Exercise $31,605 +30,684 +27% $1.03 144,833 06 Mar 2024 Direct F1
transaction IPSC Common Stock Sale $152,340 -30,684 -21% $4.96 114,149 06 Mar 2024 Direct F1, F2
transaction IPSC Common Stock Options Exercise $23,516 +22,831 +20% $1.03 136,980 07 Mar 2024 Direct F1
transaction IPSC Common Stock Sale $117,342 -22,831 -17% $5.14 114,149 07 Mar 2024 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IPSC Stock Option (right to buy) Options Exercise $0 -30,684 -14% $0.000000 191,486 06 Mar 2024 Common Stock 30,684 $1.03 Direct F1, F4
transaction IPSC Stock Option (right to buy) Options Exercise $0 -22,831 -12% $0.000000 168,655 07 Mar 2024 Common Stock 22,831 $1.03 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2022.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.85 to $5.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 and 3 to this Form 4.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.87 to $5.48, inclusive.
F4 The option is fully vested and exercisable.